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Wisdom is knowing which 
path to choose next. Integrity is taking it. 
And the corollary: Age doesn't always bring wisdom ... 
sometimes age comes alone. Hmmm. 
Communication 
It is hard to overestimate the importance of communication in 
our modem society - and the significant communication 
changes that we have all seen in the form of e-mail, web sites, 
teleconferences and the now essential cellular phones. There 
is the art and the science of communication, the personal and 
the impersonal. Man is a social animal and usually needs to 
communicate in one form or another. Because of the personal 
nature of healthcare, we are frequently dealing with people 
(patients and families}, in one capacity or another, often 
discussing topics of personal risk. Better techniques of 
communication would make us more effective and make our 
jobs more satisfying. 
Patients- The Hospital Association of Pennsylvania is 
sponsoring workshops aimed at helping clinicians 
communicate better with patients. I will be attending the first of 
these later this month and plan to share the key points with 
you. Patients who feel connected to their physicians are more 
likely to ask questions, participate in decisions and have better 
health outcomes. Better communication with patients might 
also avoid unrealistic expectations of healthcare interventions 
and avoid surprises. 
Physicians - Better communication between and among 
healthcare providers might improve patient care and 
coordinate both our hospital and outpatient care. It could also 
serve as a source of mutual support for caregivers who could 
understand each othe(s problems and concerns. I am all 
about communication since it is essential to team building -
and today's healthcare is a team effort. Each member of the 
team is important in his/her own way and must view his/her 
task as essential to the success of the team. Winning teams 
support and value one another - true in basketball and 
healthcare. 
We must remember that LVHHN's greatest asset is its 
workforce, and retention strategies need communication with 
all involved. 
(Continued on Page 2) 
(Continued from Page 1) 
When you love something, set it free. 
If it comes back to you, ifs yours. 
If it doesn't, it never was. 
- Folk Wisdom 
What ever happened to those goals for the Medical Staff 
leadership? 
Respect: We said we would value and respect the individual 
contribution of every member of the medical staff and assume 
positive intent. We have done that in a variety of contexts and 
will continue to do so. 
Communicate: We have visited Division meetings and reached 
numerous staff members in person or by phone for their input 
on the LVH medical staff. We have used e-mail plus the 
written monthly Medical Staff Progress Notes. I am working 
to improve our performance in this vital area. 
Advise: We continue to identify and analyze trends and 
developments in the world of healthcare and relate them to the 
ifiedical staff for their awareness. 
~epresent: Medical staff leadership understands that our 
primary goal is to represent the diverse interests of the medical 
staff, as best we can, and to act on your behalf. While most 
issues are straight forward, some are complex and may 
require consultation with various medical staff members. 
A banker is a fellow who lends you his umbrella when the sun 
is shining, and wants it back the minute it begins to rain. 
-Mark Twain 
Autonomy is an important aspect of our function as a medical 
staff and requires motivation and interest in traditional medical 
staff duties. The present structure of a medical staff 
organization with departments, divisions and committees 
allows individual input and quality improvement assessment. It 
works as long as the medical staff stays involved and focused. 
Professionalism - a professional is always the patient's 
advocate. He/she assures that decisions are made by those 
who cleariy understand the priority of patient care issues and 
quality of care. We need to participate in governance issues of 
healthcare delivery systems and managed care forums. As 
respected voices in our communities, we need to influence and 
mold the political process at various levels. Medical staff 
leadership understands your competing time pressures and 
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concerns: the unfair Medicare physician payment reduction, 
the impact of HIPAA on your office, bioterrorism, malpractice, 
EMTALA, ER call schedule, hospital staff shortages, 
institutional competition. And after all this, I want you to 
become involved in the political process and call your state 
representative? Are all these items important? Of course, just 
like your pension/profit-sharing plan and your office staffing 
problems. Some days, life can be stressful and it feels like we 
are on a treadmill- Level 9. On the other hand, we cannot 
forget the prime reason we are in healthcare. We have a 
fiduciary responsibility to patients to protect their interests. We 
are professionals. 
"There is nothing more difficult to take in hand, more perilous 
to conduct, or more uncertain in its success than to take the 
lead in the introduction of a new order of things. • 
- Niccolo Machiavelli 
CAPOE Rollout Plans - Increasing numbers of 
medical staff members have been trained and are 
now using the computer assisted physician order 
entry on 68 and the TTU. The feedback has been 
positive and the Information Services personnel have 
done everything possible to make it an easy 
transition. They usually have a representative 
stationed on the unit during the day. Your Troika 
membership has tried it and it has worked well for us. 
We would like to thank Dr. Don Levick, Information 
Services, and the CAPOE Design Committee for their 
considerable work in designing this system - which is 
a fluid and dynamic program - continually evolving 
and improving. Recently, LVHHN was recognized by 
the Leapfrog Group as a Pennsylvania leader in using 
CAPOE to reduce medical errors and improve patient 
safety. As noted below, they are active ... 
A CONSORTIUM OF LARGE EMPLOYERS AND HEALTH 
CARE PURCHASERS PLANS TO RATE HOSPITALS BY 
THEIR ADHERENCE TO COMPUTERIZED PHYSICIAN-
ORDER ENTRY SYSTEMS. 
The Leapfrog Group sees the system as one of three practices 
that can reduce preventable mistakes in hospitals; the other 
two are sticking to guidelines for treatment of high-risk 
conditions and proper staffing levels in intensive care units, 
reported the Wall Street Journal. Doctors would use such a 
system by inputting every prescription and order for drugs, lab 
tests and procedures, while the computer program then 
responds with alerts for drug allergies and interactions and 
information on new therapies, the Journal noted. Wall Street 
Journal, March 15, 2002 
(Continued on Page 3) 
(Continued from Page 2) 
•!• Dijon Vu -the same mustard as before 
•!• Shotgun wedding - a case of wife or death 
•!• A gossip is someone with a great sense of rumor. 
Edward M. Mullin, Jr., MD 
Medical Staff President 
News from CAPOE Central 
As many physicians are aware, CAPOE went live on 6B at 
Cedar Crest & 1-78 on February 20, 2002. The process has 
gone quite well- the Internal Medicine residents have been 
very compliant with entering orders on-line, and several 
residents have entered ALL their orders on-line. The Internal 
Medicine and Neurology attendings have been very 
cooperative, with most of them entering orders on-line and 
showing great patience as the residents learn the system. The 
support on 6B and TTU by the CAPOE team has been a 
critical part of the success. I would like to congratulate 
everyone involved for their hard work and commitment to the 
project. 
Several physicians have asked why the Vital Signs (VS) and 
the Medication Administration Record (MAR) are now available 
only on-line, and are not being printed. All of the decisions in 
the CAPOE project are being driven by the goal of improving 
quality of care and improving patient safety. By charting VS 
and MAR on-line, we are able to ensure more accurate and 
timely data. The on-line record will always reflect the most 
recent data available for a patient. Printing the patient data will 
create confusion regarding which is the most up-to-date . 
record, and will create duplicative work for people. Recording 
medications on-line will contribute to decreasing errors in 
transcription and administration. This process will also 
integrate into potential future technologies that will further 
reduce or eliminate medication errors. By having this patient 
data on-line, it is available remotely - from any unit, the 
Medical Staff lounge, the physician's office, or from home. We 
can build decision support tools that integrate with the data -
alerting physicians or nurses about potential problems, 
triggering of events (CBC and cultures when fever is recorded 
on-line). Using the "Viewer,• physicians can create custom 
views and graphs that highlight specific parameters. We have 
set up a view for the Infectious Disease physicians that 
automatically graphs temperature vs. WBC counts. We have a 
view that shows and graphs coagulation labs against anti-
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coagulant medication doses. Having the data on-line will also 
allow us to capture the data and help analyze outcomes and 
medical quality. 
We believe, as has been shown in the literature, that the 
benefits of computer physician order entry and on-line 
documentation of medication administration outweigh the work 
of learning the change in process. 
I appreciate that this system requires access to a computer 
and that log-in time has been an issue. We are addressing 
this in several ways, and continue to evaluate new options. 
Many groups have been offered handheld computers 
(PenCentras). By carrying the computer around, the number 
of log-ins is greatly reduced or eliminated. Although carrying a 
device is a change in work habits, we believe the benefits are 
worth considering. There are four laptops on carts located 
throughout each CAPOE unit. These are available for use by 
the medical staff. We have evaluated these units, and have 
found login time to be consistently less than thirty seconds. 
Screen clarity is excellent, and response time is very fast. The 
existing workstations are also available for use, and are being 
monitored to keep them running as fast as possible. 
We have deliberately paced the rollout of CAPOE units to 
allow the medical staff time to acclimate to the new system and 
for the CAPOE team to respond to user requests and 
enhancements. 
Please contact me with any questions or if you would like more 
information. 
Don Levick, MD, MBA 
(484) 884-4593 (office) or (610) 402-5100 7481 (pager) 
? ? ? Mystery Medical Staff Member ? ? ? 
? Born in Wilmington, Del. 
? Earned Bachelor of Arts degree from the 
University of Delaware 
? Graduated from the University of Pennsylvania 
School of Medicine 
? Completed rotating internship at York Hospital 
? Completed three-year residency at the . 
University of Pennsylvania Hospital 
? Joined the Medical Staff in 1975 
? Wife's name is Patricia 
? Two children and one grandchild 
? Drives a Silver BMW 
? Enjoys gardening, golfing, fishing, sailing and 
playing bridge 
Give up? Please see Page 12 for the answer. 
Medical Staff Pro ress Notes April, 2002 
Spotlight on ... 
---f T -:r.· 
-,~  ~ Larry R .. Glazerman, MD 
, ~ Born 1n Ph1ladelph1a, Pa., Dr. 
Glazerman completed his 
undergraduate education at 
Muhlenberg College in Allentown, Pa., where he earned a 
Bachelor of Science degree. He received his medical degree 
from Jefferson Medical College of Thomas Jefferson University 
in Philadelphia, Pa. He completed a four-year Obstetrics and 
Gynecology residency at Lehigh Valley Hospital (formerly 
known as the Allentown Affiliated Hospitals). Dr. Glazerman is 
certified and recertified by the American Board of Obstetrics 
and Gynecology. He is also certified by the Accreditation · 
Council for Gynecologic Endoscopy. 
Dr. Glazerman joined the hospital's Medical Staff in 1980, and 
is a member of the Department of Obstetrics and Gynecology, 
Division of Primary Obstetrics and Gynecology. He is a 
Clinical Assistant Professor of Obstetrics & Gynecology at 
Pennsylvania State University College of Medicine. Dr. 
Glazerman is in private practice with OB-GYN at Trexlertown, 
PC. Among his interests are computers in medicine and 
laparoscopic surgery. In fact, he performed the first 
laparoscopic hysterectomy in the Lehigh Valley. 
On a more personal note, Dr. Glazerman and his wife, Joan, 
have three children. In his spare time, Dr. Glazerman enjoys 
golf, skiing, and computers. Though a Philadelphia native, he 
now considers the Lehigh Valley as home, and only returns to 
Philadelphia for cheesesteaks, soft pretzels, and sporting -
events. 
In conclusion, Dr. Glazerman has the following comments to 
share with his colleagues on the Medical Staff: 
• Change is inevitable. Those who embrace change 
and look for opportunity in it will thrive. (Everyone 
should read "Who Moved My Cheese• by Spencer 
Johnson, MD.) 
• What's true today won't be true tomorrow. This is as 
true in medicine as in other parts of our lives. 
• In the turbulent times we're in, it's sometimes hard to 
sort out the players, and who's on which side. 
Remember that we're on the side of the patients! 
• Remember that we're our patients' partners. Our job 
is to inform and advise them, not to be the ultimate 
authority on decisions that affect their health. 
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Dental Consultations 
The Department of Dental Medicine would like to remind the 
Medical Staff that the six dental residents are available to 
perform in-patient dental consultations at all three hospital 
campuses. Consults at 17th & Chew or Cedar Crest & 1-78 
must be forwarded through Lastword to the Dental Clinic at 
17th & Chew. Consults at LVH-Muhlenberg must be forwarded 
through Lastword to the Dental Center at LVH-Muhlenberg. It 
is also recommended that a phone call be placed to the 
appropriate dental clinic in conjunction with the request via 
Lastword. Please remember to include the Reason for 
Consultation. For example, appropriate reasons include the 
following: 
evaluation of intraoral lesions, swelling and/or infection; trauma 
to teeth and/or jaws, pre-operative evaluation prior to heart 
valve replacement, organ transplants, or radiation/oncology 
treatment. 
Please do not request consultations for elective treatment such 
as cleaning of teeth, fillings, denture relines, or orthodontic 
treatment. Patients requiring these treatments should be 
referred for dental care after discharge. 
If you have any questions, please contact one of the Dental 
Residency Program Directors: Charles J. lncalcaterra, DMD, 
17111 & Chew- (610) 402-2245, or Russ S. Bergman, DMD, 
LVH-Muhlenberg- (484) 884~2315. 
In celebration of Nurses Week, 
members of the Medical Staff 
are cordially invited to attend the 
2002 Nursing Gala 
honoring our staff 
and the Friends of Nursing 
award winners and donors. 
Thursday, May 2, 2002 
Holiday Inn Conference Center 
Fogelsville, Pennsylvania 
5:30 p.m. - Reception 
7 p.m. -Awards Presentation 
RSVP by Friday, April26, 2002 
to Kim Hitchings at (610) 402-1704 
Ethics Corner 
by Glenn A. Mackin, MD, Chairperson, Ethics Committee 
Before embarking on my six-month series of commentaries on 
the AMA's important new Ethical Guideline E-8.061, "Gifts to 
Physicians from Industry", a few words of thanks are in order. 
To my medical staff colleagues, it is a privilege for me to 
practice medicine alongside you, to learn from you, and be 
constantly inspired by your dedication-and Lehigh Valley 
Hospital's-to the highest standards of scientific and 
compassionate care individualized for each and every patient. 
I am honored and grateful for the opportunity to serve you and 
our great institution as Chairman of the LVH Ethics Committee. 
Many thanks to Joseph E. Vincent, MD, my predecessor as 
Ethics Chairman-now Vice Chairman-for his astonishing 
range of substantive contributions to the ethical environment in 
which we practice, his wit, wisdom and support. LVH is a 
better place to receive and provide medical care as a result of 
the remarkable dedication our academic ethicist, Stephen 
Lammers, PhD, Professor of Religion at Lafayette, whose 
many years with the LVH ethics program have elevated our 
ethical discourse, sharpened our policy language and 
strengthened our educational programs. Every active 
committee member enriches our consults, monthly meetings 
and projects by providing unique experience, perspective and 
candor. Special thanks to Nancy Stevens, our longtime 
member and recenHy retired Patient Representative. 
The Ethics Committee needs more physician-members to 
attend our monthly meetings, and to participate in our inpatient 
consultations. I invite and encourage you to join our 
Committee. 
Last but not least, thanks to Troika for inviting me to provide 
commentary on the AMA's recent Ethical Guideline E-8.061, 
"Gifts to Physicians from Industry: I suggest that you visit the 
AMA website to review the Guidelines (also in March 2002 
Medical Staff Progress Notesl and official answers to 
frequenHy asked questions (from which my commentaries 
draw). Concern about maintaining a proper relationship 
between medical staff and the pharmaceutical industry is by no 
means new to LVH. Dr. David Caccese has long served as 
our institutional conscience on this matter. The main purpose 
of my writing these commentaries is to encourage you to read 
the AMA Guidelines yourself. My views are offered as one 
physician's perspective, and with utmost respect for you. 
Why be concerned about pharmaceutical influence? There 
are, after all, so many other things to worry about as we try to 
provide high-quality care despite too little time and too many 
obstacles. To borrow a metaphor from the Old West, the 
pervasiveness of drug promotion today is such that if 
physicians resolved tomorrow to "circle the wagons" to 
eliminate it, we would find drug logos printed all over the inside 
of the wagon covers! As an experiment, try to go a week 
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without using or displaying a physical advertisement for a 
pharmaceutical product. Specifically, try to make it from 
Monday morning to Friday afternoon without writing with a pen, 
using a sticky or notepad, or inadvertently carrying an 
implement in your lab coat-emblazoned with a drug name or 
company logo. Recently, I attended a steering committee 
meeting overseeing planning for a large specialty society 
annual meeting. One irrepressible colleague, concerned with 
the growing industry presence at recent meetings, displayed a 
T -shirt he had made with the specialty society's logo 
surrounded front and back with drug company logos, 
reminiscent of a NASCAR driver's suit. While the intent of his 
theatrics was to warn us about future conflicts of interest, 
actual and apparent, the most telling irony was that about half 
the committee thought the T -shirt was "real·! 
The first "buller in the AMA Guidelines E-8.061, "Gifts to 
Physicians from Industry" is: 
• Any gifts accepted by physicians individually 
should primarily entail a benefit to patients and 
should not be of substantial value. Accordingly, 
textbooks, modest meals, and other gifts are 
appropriate if they serve a genuine educational 
function. Cash payments should not be accepted. 
The use of drug samples for personal or family 
use is permissible as long as these practices do 
not interfere with patient access to drug samples. 
It would not be acceptable for non-retired 
physicians to request free pharmaceuticals for 
personal use or use by family members. 
The theme of this "buller is the fiduciary duty at the heart of 
the physician-patient relationship, namely, that the physician 
has a duty to put the interests of patients first. The guideline 
allows gifts that "primarily entail a benefit to patients" and serve 
a "genuine educational function•, but lays the groundwork-
developed in subsequent "bullets"-forthe application of these 
criteria. 
The business interest of pharmaceutical companies is to see 
their products chosen over those of the competition. When a 
physician accepts gifts that amount to "perks• to the physician 
as a physician, studies show these tend to create subtle bias 
and product name recognition that may subordinate the 
patient's interest. The patient's interest is to receive balanced 
information on the most appropriate drug (and non-drug) 
alternatives tailored to the patient's specific problem. In ethical 
terms, the patient has an autonomy interest in shared decision-
making with the physician over the trajectory of treatment and 
important alternatives. From the patient's perspective, key 
parameters include efficacy, cost, side effects and drug 
interactions, not hospitality or largesse lavished upon the 
patient's physician. In principle, the physician could disclose 
(Continued on Page 6) 
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the specific gifts received in relation to each drug being 
recommended. In practice, this probably occurs rarely, if for 
no other reason than that the physician's recollection is usually 
not of specific gifts or events attended, but rather a positive 
disposition toward a product, which was the very point of the 
gift. 
The AMA answers to frequently asked questions make the 
following helpful points. Diagnostic equipment (e.g., 
stethoscopes) may be accepted as gifts, as they primarily 
benefit the patient, if they are "not of substantial value", 
measured by what they would cost the physician to purchase. 
Invitations to attend a dinner with a speaker-where the · 
company promises to donate $100 to a charity or medical 
school on behalf of the physician-are a judgment call, but do 
not raise ethical concerns if the "charity is predetermined 
without the physician's input". Concerning company-
sponsored dinners featuring a speaker, the guidelines specify 
that the dinner must be a "modest meal," that any gifts (e.g., 
textbooks) primarily benefit patients and not be of substantial 
value (i.e., not exceed $100), and that educational component 
of the event have "independent value". Specifically, the 
presentation should be by an "authoritative speaker" and not a 
company sales representative. The "modest meal" should be 
"similar to what a physician routinely might have when dining 
at his or her expense". (Meals accepted in the office or the 
hospital as part of a meeting with a company representative 
should likewise be of "nominal value", e.g., a sandwich or 
snack.) Vouchers to reimburse physicians for uncompensated 
care are not acceptable, because these are direct physician 
income. Accumulation of "points" over several educational or 
promotional meetings that could be redeemed toward gifts 
from an educational catalogue are acceptable only if they do 
not add up to a gift of substantial value. Gift certificates for · 
attending educational or promotional meetings are a gray area, 
as the guidelines permit medical textbooks or selection from a 
medical textbook catalogue. On the other hand, gift 
certificates can function as cash if the recipient has an 
unlimited number of choices in their redemption. Thus, to 
guide physicians in making this judgment call, the AMA 
recommends that the number of choices be limited (arbitrarily) 
to approximately eight, and the value of the gift finally chosen 
not exceed $100. 
The following are the AMA's verbatim recommendations on 
personal or family use of free pharmaceuticals: They are 
permitted "(i) in emergencies and other cases where the 
immediate use of a drug is indicated, (ii) on a trial basis to 
assess tolerance, and (iii) for the treatment of acute conditions 
requiring short courses of inexpensive therapy, as permitted by 
Opinion E-8.19: Self-Treatment or Treatment of Immediate 
Family Members. It would not be acceptable for physicians to 
accept free pharmaceuticals for the long-term treatment of 
chronic conditions." 
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Please contact me with your questions, suggestions or 
concerns. 
Glenn A. Mackin, MD 
Office: (610) 402-8420 
Computer-Based Training (CBT) 
Beginning April 2002, the Information Services department will 
assume responsibility for the computer-based training (CBT) 
programs available to Lehigh Valley Hospital (LVH) staff. CBT 
programs replace the instructor-led classes previously held at 
LVH. A proctor will be in the room with the learner while 
he/she takes the CBT, but the Ieamer will control the pace and 
objectives of the learning. 
Topics covered by the CBT programs include: 
~Access 97 
~Word 97 
~ PowerPoint 97 
~ Windows NT 4 
~ GUI Email 
~ Excel97 
Computer-based training is held in Suite 401 of the John & 
Dorothy Morgan Cancer Center (the training room) and in 
the Lehigh Valley Hospital-Muhlenberg liS training room 
(off the front lobby). The 2002 schedule of classes include: 
2002 CBT Sessions •• JDMCC, Suite 401 










December 18 (noon - 4 p.m.) 
2002 CBT Sessions .. LVH·Muhlenberg, liS Training Room 





June 20 July 18 
September 19 October 17 
December 19 (8 a.m.- noon) 
Twelve seats are available at each session. To register for a 
session in email, go to either the Forms_ILVH or 
Forms_IMHC bulletin board, (based on your choice of site 
and training room). The form has all the available information 
in an easy to choose format, detailing titles, dates, times, and 
locations. Simply do a "Use Form" (a right mouse option) on 
the liS Computer Educ Request form. Complete the form 
indicating your desired session selection and mail the form. 
Shortly, you will receive a confirmation notice. 
If you have any questions, please contact Information Services 
by calling the Help Desk at (610) 402-8303 and press option 
"1. • Tell the representative that you need assistance with liS 
education. 




Given the recent controversy regarding the use of screening 
mammography, it should be noted that a government task 
force has recently come out in support of screening 
mammography. Members of the Department of Radiology-
Diagnostic Medical Imaging support the recommendations of 
the American College of Radiology, the American Cancer 
Society, and the American College of Obstetrics and 
Gynecology in recommending annual mammography for 
women ages 40 and older. 
Locally, Breast Health Services has passed MQSA inspection 
at all sites in the network with no contingencies (something 
that is accomplished by less than 5% of the sites that are 
inspected in this country). This includes the sites at Cedar 
Crest & 1-78, LVH-Muhlenberg, Allentown Breast Diagnostic· 
Center (ABDC), Trexlertown, Bath, Kutztown, and Hamburg. 
PET Scan 
The Center for Medicare and Medicaid Services has approved 
PET scans for staging and restaging of breast cancer as well 
as for monitoring response to treatment in women with locally 
advanced or metastatic breast cancer. PET scans have been 
shown to change clinical stage in 36% and management in 
58% of patients with breast cancer according to an article by 
Yap et al, Journal of Nuclear Medicine, Vol42, No 9, 
September, 2001, pp 1334-1337. 
If you believe your breast cancer patient can benefit from a 
PET scan, call toll-free 1-866-235-7226 for scheduling. If you 
have any questions regarding this issue, please call either 
Robert J. Rienzo, MD, or Kathleen L. McDonald, MD, in 
Nuclear Medicine at (610) 402-8373. 
CCK is Now Available 
As you may know, over the past several months, the Section of 
Nuclear Medicine was unable to offer patients gallbladder 
stimulation studies with cholecystokinin (CCK) because of a 
manufacturing problem. Nuclear Medicine is pleased to 
announce that they have found a pharmacy in Oklahoma that 
makes Sincalide (the chemical form of cholecystokinin), which 
is similar to the original product, Kinevac. The new product is 
pyrogen free and sterile and is considered to be as safe and 
effective as the original Kinevac. 
Nuclear Medicine has also altered the method of administering 
the CCK in that they now give .02 microgram per kilogram over 
a 30 minute timeframe rather than over a three minute 
timeframe since this has proven to be more physiologic in the 
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recent literature. Nuclear Medicine images the patients over 
the course of 30 minutes and calculates the gallbladder 
ejection fraction. Values at or above 35% are considered to be 
normal. The patient may not experience pain after CCK 
infusion even with scintigraphic evidence of gallbladder 
dyskinesia. 
These studies are typically outpatient studies and may be 
scheduled through the Centralized Scheduling Departments at 
both Cedar Crest & 1-78, (610) 402-8378, and LVH-
Muhlenberg, (484) 884-2279. 
News from Health Information 
Management 
Physician Query Process 
In the circumstance when unclear or conflicting documentation 
exists within the medical record, a physician query will be 
generated to clarify the diagnosis/procedure. 
The physician will provide the requested additional clarifying 
documentation via a dictated addendum to the medical record. 
The process for the addendum is as follows: 
1) Physicians will dictate the query response on transcription 
work type ·so• to distinguish the addendum from other 
transcriptions. Physicians will need to indicate "Dictate• 
for the deficiency. 
2) Remember to include the patienfs name, medical record 
number, discharge date, and account number. 
3) When the physician completes the dictation deficiency, 
he/she will need to "hir the complete button, which will 
remove the deficiency. 
Please remember when addressing the query, the query 
form is NOT part of the permanent medical record. One-word 
answers or diagnoses will not clarify the present 
documentation in the record. Always answer the query in 
sentence form (i.e., chest pain secondary to CAD; altered 
mental status due to UTI, etc.). 
If you have any questions regarding this issue, please contact 
Karen Caravetta, CCS, Team Leader, Coding, at (610) 402-
2874. 
Medical Staff Pro ress Notes April, 2002 
Coding Tip of the Month 
Acute Ml: When documenting an acute Ml, it 
is important to document "acute Ml" and specify 
whether it was subendocardial, non-Q wave 
Ml, or nontransmural. If transmural, give 
specific site. ST and non ST Mls are not 
codeable. 
When there are positive troponins or positive 
MIP, always specify the etiology of the 
abnormal lab findings. For example, acute Ml, 
sepsis, renal failure, etc. 
CHF: When the diagnosis of CHF is 
established, please document the etiology. For 
example, if acute Ml, ischemic cardiomyopathy, 
medication noncompliance, valvular 
dysfunction, CAD, etc. 
Pleural Effusion: When there is pleural 
effusion, please document the etiology if 
known. For example, secondary to CHF, due 
to malignancy, secondary to pneumonia, etc. 
Pulmonary Edema: It is important to 
::ocument whether pulmonary edema is cardiac 
on non-cardiac related. When non-cardiac 
related, document also the likely cause. 
Cardiomyopathy; It is important to document 
whether the etiology of cardiomyopathy is due 
to hypertension, ischemic disease, vascular 
disease, viral illness, or poisoning and whether 
it is congenital, hypertrophic, or IHSS. 
Angina: Angina is usually a symptom of an 
underlying disease process. Please document 
the etiology of the angina and whether it is 
considered stable or unstable. When 
specifying unstable angina, define what makes 
it unstable. 
Papers, Publications and Presentations 
Kelly M. Freed, MD, Division of Diagnostic Radiology, 
published an article, "Comparison of MR 
Cholangiopancreatographic Techniques with Contrast-
enhanced Cholangiography in the Evaluation of Sclerosing 
Cholangitis,• which was published in the February, 2002 
edition of the American Journal of Radiology. The article 
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evaluated MRCP and ERCP in patients with sclerosing 
cholangitis and normal patients. MRCP was comparable to 
ERCP in assessing biliary strictures and superior in 
visualization of intrahepatic biliary ducts. 
Herbert L. Hyman, MD, Division of Gastroenterology, 
presented "Psychosomatic Medicine• to the Department of 
Obstetrics and Gynecology at The Reading Hospital and 
Medical Center in late February. 
Peter A. Keblish, Jr., MD, Division of Orthopedic Surgery, 
Section of Ortho Trauma, published an article in Orthopaedics 
supplemental February 2002 issue. The article was "Alternate 
Surgical Approaches in Mobile-Bearing Total Knee 
Arthroplasty. • 
lndru T. Khubchandani, MD, Division of Colon and Rectal 
Surgery, was an invited participant at the IV International 
Pelvic Floor Dysfunction meeting, held in Taormina, Sicily from 
March 12 to 16, where he gave a lecture on "Intra-rectal Ultra 
Sound" and chaired and moderated sessions on various pelvic 
floor disorders. 
Howard S. Selden, DDS, Division of Endodontics, authored 
the paper, "The Dental-Operating Microscope and Its Slow 
Acceptance,• which was published in the March, 2002 issue of 
the Journal of Endodontics. 
Upcoming Seminars, Conferences and 
Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room at LVH-Muhlenberg. Topics to be discussed in April will 
include: 
~ April2- "HIV and Kidney Disease• 
~ April 9 - "The Challenges of Managing the Injured Worker" 
~ April16 - "Clinical Aspects of Systemic Sclerosis 
(Scleroderma)" 
~ April17* Special Medical Grand Rounds - "Maximizing the 
Interview" 
~ April 23 - "New Advances in Steroid Management of IBD" 
~ April30- "Airway Remodeling- Fact or Fiction" 
For more information, please contact Diane Biernacki in the 
Department of Medicine at (610) 402-5200. 
(Continued on Page 9) 
(Continued from Page 8) 
Department of Pediatrics 
Pediatric conferences are held every Tuesday beginning at 8 
a.m., in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78. Topics to be discussed in April will include: 
} April2- ·case Presentation• 
} April 9 - ·current Management of Bums• 
} April16 - "Chiere I Malformation" 
} April 23 - •case Presentation• 
} April 30 - • Attention Deficit Hyperactivity Disorder" 
For more information, please contact Kelli Ripperger in the 
Department of Pediatrics at (610) 402-2540. 
Psychiatry Grand Rounds 
"An Integrated Approach to IBS Objectives• will be presented 
on April18, from noon to 1 p.m., at LVH-Muhlenberg, in the 4111 
Floor ER Conference Room. 
If you have any questions or for more information, please 
contact Audrey Mclaughlin in the Departmen~ of Psychiatry at 
(484) 884-6501. 
Who's New 
The Who's New section of Medical Staff Progress Notes 
contains an update of new appointments, address changes, 
resignations, etc. Please remember to update your directory 
and rolodexes with this information. 
Medical Staff 
Appointments 
Fred J. Bonacci, DMD 
In practice with Joseph R. Loiacono, Jr., DDS 
764 Main Street 
Peckville, PA 18452-2306 
{570) 383-2411 
Fax: (570) 383-6954 
Department of Dental Medicine 
Division of General Dentistry 
Provisional Active 
Site of Privileges - LVH & LVH-M 
Barbara C. Cavanaugh, MD 
Medical Imaging ofLV, PC 
Lehigh Valley Hospital 
Cedar Crest & 1-78, P.O. Box 689 
Allentown, PA 18105-1556 
(610) 402-8088 
Fax: (610) 402-1023 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Provisional Active 
Site of Privileges - LVH & L VH-M 
Kathya M. Darmos, DPM 
Kramer & Maehrer LLC 
2597 Schoenersville Road, Suite 304 
Bethlehem, PA 18017-7309 
(610) 868-6353 
Fax: (610) 694-9719 
Department of Surgery 
Division of Podiatry 
Provisional Active 
Site of Privileges - LVH & LVH-M 
James F. Frommer, Jr., DO 
(Solo Practice) 
65 E. Elizabeth Avenue, Suite 206 
Bethlehem, PA 18018-6506 
(610) 691-8537 
Fax: (610) 691-8420 
Department of Family Practice 
Provisional Active 
Site of Privileges - LVH & LVH-M 
Ann M. McGeehan, MD 
Medical Imaging of LV, PC 
Lehigh Valley Hospital 
Cedar Crest & 1-78, P.O. Box 689 
Allentown, PA 18105-1556 
(610) 402-8088 
Fax: (610) 402-1023 
Department of Radiology-Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Provisional Active 
Site of Privileges - LVH & LVH-M 
Douglas D. Semian, MD 
LVH Department of Medicine 
Lehigh Valley Hospital 
Cedar Crest & 1-78, P.O. Box 689 
Allentown, PA 18105-1556 
Department of Medicine 
Division of General Medicine 
Provisional Limited Duty 
Site of Privileges - LVH & LVH-M 
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Medical Staff Progress Notes 
(Continued from Page 9) 
Status Changes 
Harvey S. Cheng, MD 
DepartmentofSu~e~ 
Division of Ophthalmology 
From: Active 
To: Affiliate 
Site of Privileges - None 
Thomas B. Dickson, MD 
Department of Su~ery 
Division of Orthopedic Surgery 
From: Active 
To: Honorary 
Mark N. Martz, MD 
Department of Su~ery 
Division of Cardia-Thoracic Surgery 
Section of Thoracic Surgery 
From: Affiliate 
To: Honorary 
Joseph T. Sembro~ MD 
Department of Medicine 
D1vision of Endocrinology 
From: Affiliate 
To: Honorary 
Nora A. Suggs, MD 
Department of Su~ery 
Division of General Su~ery 
From: Active 
To: Honorary 
One-Year Leave of Absence 
Francis S. Kleckner, MD 
Department of Medicine 
Division of Gastroenterology 
From: Active 
To: Active/LOA 
Phone Number Change 
Peter T. Ender, MD 
Jeffrey A. Jahre, MD 
Thong P. Le, MD 
(610) 954-4000 
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Change of Address 
Eva R. Michael, MD 
2527 East Texas Blvd. 
Allentown, PA 18103-2899 
(610) 820-0477 
Fax: (610) 434-7332 
William A. Ofrichter, DPM 
2030 Center Street, Suite 101 
Northampton, PA 18067-1321 
(610) 261-1001 
Fax: (610) 261-2589 
Robert W. Vaughn, MD 
8360 Holbens Valley Road 
New Tripoli, PA 18066-3506 
(610) 298-2959 
Change of Practice/Address 
Maria Jones, MD 
Bmdjar & Freeman Medical Associates, PC 
4 W. Main Street 
Macungie, PA 18062-1309 
(610) 967-4993 
Fax: (610) 967-6553 
Martin LeBoutiller Ill, MD 
Chester County Cardiovascular Surgical Associates 
701 E. Marshall Street 
West Chester, PA 19380-4412 
(610) 738-2690 
Fax: (610) 738-2696 
Joseph B. Lennert, MD 
Northgate Urology Associates 
5325 Northgate Drive, Suite 203 
Bethlehem, PA 18017-9410 
(610) 867-3171 
Fax: (610) 867-1941 
John B. Paulus, DO 
Lehigh Internal Medicine Associates 
Atrium Building 
2895 Hamilton Blvd., Suite 101 
Allentown, PA 18104-6192 
(610) 439-0303 
Fax: (610) 439-1157 
Robin A. Skrine, MD 
Breast Care Specialists, PC 
1240 S. Cedar Crest Blvd., Suite 205 
Allentown, PA 18103-6218 
(610) 433-7700 
Fax: (610) 433-8014 
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Medical Staff Pro ress Notes 
(Continued from Page 10) 
Resignations 
Samuel Abramovitz, MD 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
Alan W. Johnson, MD 
Department of Family Practice 
Joe Lee, MD 
Department of Medicine 
Division of Physical Medicine-Rehabilitation 
Orazio Prestifilippo, MD 
Department of Family Practice 
Harvey T. Starr, DO 
Department of Medicine 
Division of General Internal Medicine 
Allied Health Professionals 
Appointments 
Frederick C. Ackler, CRNA 
Physician Extender 
Professional - CRNA 
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin, 
Jr., MD) 
Site of Privileges - LVH & LVH-M 
Theresa M. Godshall, CRNA 
Physician Extender 
Professional - CRNA 
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin, 
Jr., MD) 
Site of Privileges - LVH & LVH-M 
Wendy A. Grose, CRNA 
Physician Extender 
Professional- CRNA 
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin, 
Jr., MD) 
Site of Privileges - LVH & LVH-M 
Carol J. Hornbuckle, RN, CRNFA 
Physician Extender 
Professional - Certified Registered Nurse First Assistant 
(Orthopaedic Associates of Allentown - Patrick J. McDaid, MD) 
Site of Privileges - LVH & LVH-M 
Zanetta L. Keddie, PA-C 
Physician Extender 
Physician Assistant- PA-C 
(Coordinated Health Systems - Leigh S. Brezenoff, MD) 
Site of Privileges - LVH-M 
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Judith A. Madaus, CRNP 
Physician Extender 
Professional - CRNP 
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(Valley Gastroenterologists - Richard L. London, MD) 
Site of Privileges - LVH & LVH-M 
Liese K. Marshall, CRNA 
Physician Extender 
Professional - CRNA 
(Lehigh Valley Anesthesia Services- Thomas M. McLoughlin, 
Jr., MD) 
Site of Privileges - LVH & LVH-M 
Jonathan L. Matzko, CNIM 
Physician Extender 
Technical-Intraoperative Neurophysiologic Monitoring 
Specialist 
(Surgical Monitoring Associates, Inc.) 
(Supervising Physician - Mark C. Lester, MD) 
Site of Privileges - LVH & LVH-M 
Sergio Rudio, Jr., PA-C 
Physician Extender 
Physician Assistant- PA-C 
(Coordinated Health Systems - Wayne T. Luchetti, MD) 
Site of Privileges - L VH-M 
Therese L. Schiowitz, CRNA 
Physician Extender 
Professional - CRNA 
(Lehigh Valley Anesthesia Services - Thomas M. Mcloughlin, 
Jr., MD) 
Site of Privileges - LVH & LVH-M 
Patricia A. Vaccaro, CRNP 
Physician Extender 
Professional - CRNP 
(Wound Healing Center- William R. Dougherty, MD) 
Site of Privileges - LVH & LVH-M 
Change of Supervising Physician 
Patricia M. Frey, RN 
Physician Extender 
Professional - RN 
(The Heart Care Group, PC) 
From: Steven L. Zelenkofske, DO 
To: David B. Goldner, MD 
Site of Privileges - LVH & LVH-M 
Susan E. Kunsman, CRNP 
Physician Extender 
Professional - CRNP 
From: Daniel E. Ray, MD- Pulmonary Associates 
To: Donald J. Belmont, MD- The Heart Care Group, PC 
Site of Privileges - LVH & LVH-M 
(Continued on Page 12) 
Medical Staff Pro ress Notes 
(Continued from Page 11) 
Mark A. Sabatino 
Physician Extender 
Technical- Pacemaker/ICD Technician 
(Guidant Corporation) 
From: Steven L. Zelenkofske, DO 
To: Bryan W. Kluck, DO- The Heart Care Group, PC 
Site of Privileges - LVH & LVH-M 
Sandra K. Stufflet, RN 
Physician Extender 
Professional - RN 
(The Heart Care Group, PC) 
From: Steven L. Zelenkofske, DO 
To: David B. Goldner, MD 
Site of Privileges - LVH & LVH-M 
Cheryl A. Tyler, RN 
Physician Extender 
Professional - RN 
(The Heart Care Group, PC) 
From: Steven L. Zelenkofske, DO 
To: David B. Goldner, MD 
Site of Privileges - LVH & LVH-M 
ow ··Jr •uospnH '3 PI8MOH 
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Resignations 
Bonita L. Budura, CRNA 
Physician Extender 
Professional- CRNA 
(Allentown Anesthesia Associates Inc.) 
Lori A. Emerich, CRNP 
Physician Extender 
Professional - CRNP 
(The Heart Care Group, PC) 
Francisco X. Lanas, PA..C 
Physician Extender 
Physician Assistant- PA-C 
(Coordinated Health Systems) 
Marie T. Myer, RN 
Physician Extender 
Professional - RN 
(The Heart Care Group, PC) 
Baoqing Wang, DABNM 
Associate Scientific 
Clinical Neurophysiologist 
(Surgical Monitoring Associates) 
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Medication Order Conflicts 
by Carolyn K. Suess, R.N. 
Physicians using CAPOE to order 
patient medications are undoubtedly 
familiar with the appearance of 
Medication Order Conflict screens. If a 
medication is ordered in CAPOE and a 
conflict of drug allergy, duplication, or 
interaction exists, the Medication Order 
Conflict warning appears (Figure 1 ). 
Each of these three types of conflicts is 
discussed in the following paragraphs. 
Therapeutic Duplicates 
A Therapeutic Duplicate conflict 
indicates the medication is in the same 
drug class as a previously ordered 
medication. The medication appears in 
the Duplicating/Interacting Drug List 
portion of the screen, providing the dose, 
and start and stop dates/times (see Figure 
1). 
You have three options to consider with 
a therapeutic duplicate: 
1. You may discontinue the previously 
ordered medication 
2. You may override the coriflict 
3. You may skip the order you are 
attempting to place 
To discontinue the previously ordered 
Figure 1 -Medication Order Conflict for a therapeutic duplication 
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medication, click on the pull-down list 
adjacent to the medication and double-
click on Discontinue as shown in Figure 
1. Click on the Process Actions button 
located at the bottom left side of the 
screen to complete the action. The 
Discontinue an Order screen opens, 
prompting you to select the appropriate 
discontinue reason (Figure 2). Double-
click on the desired discontinue reason, 
then click on the Send button located on 
the bottom left side of the screen. 
If you wish to override the conflict 
warning, simply click on the Place 
Order button located on the bottom left 
side of the Medication Order Conflicts 
screen (Figure 1 ). 
If you wish to skip the order, click on the 
Skip Order button, located on the 
bottom right side of the screen (see 
Figure 1). 
Drug Allergy Conflicts 
A drug allergy conflict indicates the 
patient has an allergy to the ordered 
medication. Allergies and reactions are 
listed under the Allergies/Reactions 
portion of the screen (see Figure 3). 
~;ill Discontinue an Order 13 
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There are two options to consider with a 
drug allergy alert: 
1. You can skip the order you are 
attempting to place 
2. You can override the conflict and 
place the order 
Should you wish to skip the order you 
are attempting to place, click on the Skip 
Order button located on the bottom 
right side of the screen. 
If you determine that the allergy or 
reaction is not severe enough for the 
medication to be contraindicated, you 
may override the conflict. To do so, 
click on the Place Order button located 
on the bottom left side of the screen. 
Drug Interactions 
If the medication you are ordering 
interacts with one that had been ordered 
previously, a drug interaction conflict 
screen appear (Figure 4). 
You have three options to consider with 
a drug interaction: 
1. You may discontinue the previously 
ordered medication 
2. You may override the conflict 
3. You may skip the order you are 
attempting to place 
To review information regarding a drug-
drug interaction, click on the pull-down 
list and select Display Interaction 
L'.:JUOIU0200ZITHHU M"' M tllli!!J 
> I 
Figure 3 - Medication Order Conflict for a drug allergy 
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Monograph (see Figure 4). If available, 
it will list severity, mechanism of action, 
and references. 
To discontinue the previously ordered 
medication, click on the pull-down list 
adjacent to the medication and double-
click on Discontinue (Figure 4). Click on 
the Process Actions button located at 
the bottom left side of the screen to 
complete the action. The Discontinue an 
Order screen opens (Figure 2), 
prompting you to select the appropriate 
discontinue reason. Double-click on the 
desired discontinue reason, then click on 
the Send button located on the bottom 
left side of the screen. 
Should you wish to skip the order you 
are attempting to place, click on the Skip 
Order button located on the bottom 
right side ofthe screen. 
If you determine that the drug interaction 
is not severe enough for the medication 
to be contraindicated, you may override 
the conflict. To do so, click on the Place 
Order button located on the bottom left 
side of the screen. 
For more information on the Medication 
Order Conflicts and other Lastword 
features, please take a moment to review 
the on-line documentation for Lastword. 
Both the CAPOE and Non-CAPOE 
Physician User Guides can be found on 
the L VHNN Intranet under the 
Resources heading Lastword for 
Physicians. 
For questions or comments regarding the 
CAPOE module in Lastword, please 
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contact one of the Physician Software 
Educators on staff: 
Lynn Corcoran-Stamm- ext. 1425 
Kimberlee Szep, R.N.- ext. 1431 
Carolyn K. Suess, R.N.- ext. 1416 
If you have training needs that pertain 
only to the Lastword system, please 
call ext. 1703. Arrangements can be 
made for training at your convenience. 
CAPOE Medication Order 
Enhancements 
by Carolyn K. Suess 
CAPOE users may have recognized 
some enhancements added to medication 
orders. Among these are therapeutic 
substitutions, maximum dosing 
parameters, and creatinine clearance 
estimates. These modifications were 
created to provide additional safety, 
clinical information, and cost 
containment when placing orders on-
line. Each is discussed in the following 
paragraphs. 
Therapeutic Substitutions 
Therapeutic substitutions are designed to 
provide therapeutic alternatives at a 
lesser cost or during times of product 
shortages. Presently, there are 
approximately 50 therapeutic 
substitutions in CAPOE. The system 
keeps the physician informed while 
placing orders and making clinical 
decisions. 
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An example of such a substitution would 
be famotidine for cimetidine. Upon 
selecting cimetidine under Medications 
A-L on the CAPOE Order Pad, a screen 
appears listing the drug that is ordered, 
and one that is available, in this instance 
famotidine (see Figure 5). The screen 
provides comparative dosing 
infonnation for each drug and 
therapeutic options. 
With this scenario, let us presume the 
physician wished to order cimetidine, 
400 mg, PO, BID. The therapeutic 
equivalent would be famotidine, 20 mg, 
PO, BID. To place the famotidine order, 
the physician would click on the 
appropriate dose listed under the 
Therapeutic Options portion of the 
screen, then click on the Select button 
located beneath the doses listed (see 
Figure 5). You may a&o double-click on 
the medication to select it. The screen 
closes and the selected therapeutic 
substitute appears in the Unprocessed 
Orders window ofthe CAPOE Order 
Pad. To process the order, click on the 
Process Orders button located beneath 
the Unprocessed Orders window. 
If the therapeutic alternative famotidine 
is not desired, click on the Back button 
to return to the order screen, and contact 
the phannacy to request cimetidine. 
Maximum Dosing 
Maximum dosing parameters are 
presently in place for over 1,000 
medications at Lehigh Valley Hospital. 
When placing a CAPOE medication 
order, this safety enhancement provides 
dosing infonnation when a maximum 
single dose, total daily dose, or dose 
based on weight is exceeded. 
Figure 6 - Acetaminophen order displaying maximum single dose warning on status bar 
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The example shown in Figure 6 displays 
an order for acetaminophen, 6500 mg, 
PO, Q6H, PRN. Upon attempting to 
place the order, a warning on the status 
bar located on the lower left margin of 
the screen appears. The warning states 
the maximum single-dose for 
acetaminophen (1 000 mg) has been 
exceeded. The maximum dose warning 
does not prevent the physician from 
placing the order, but is only 
informative. 
Creatinine Clearance Estimates 
Creatinine clearance is used to adjust 
dosages for renally eliminated drugs, or 
to monitor patients on nephrotoxic 
drugs. By providing a creatinine 
clearance estimate upon placing a 
medication order, the physician can 
adjust medication dosing as indicated. 
Presently, there are five medications that 
provide an estimated creatinine 





Metformin HCI (Giucophage) 
Upon placing an order for one of these 
medications, an alert appears displaying 
the patient's most recent serum 
creatinine, body weight, height, age, sex, 
calculated ideal body weight, and the 
creatinine clearance estimate based on 
the Cockcroft-Gault formula (see Figure 
7). 
The system enhancements discussed in 
the previous paragraphs are a direct 
result of physician feedback. That is why 
your input is so important. Please take a 
moment to share your thoughts and ideas 
7 
concerning CAPOE or Expert Rule 
development with Dr. Donald Levick. 
Dr. Levick can be paged at (610) 402-
5100, ID #7481. 
Figure 7 -Creatinine Clearance Estimation 
CAPOE: Fact vs. Fiction 
by Carolyn K. Suess. R.N. 
In the February 2002 issue of The Last 
Word, an article titled CAPOE: What's it 
All About? attempted to dispel some 
preconceived notions regarding 
Computer Assisted Physician Order 
Entry. With the recent activation of 
CAPOE on 6B, here are a few more 
myths that should be added to the list: 
Myth #1: As a CAPOE user, I 
cannot activate a patient by 
Medical Record Number in the 
Lastword system 
Although patient lists are available for 
use in the Lastword (Phamis) system, 
you do have the option to search for a 
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patient by medical record number. 
Simply click on the MRN search field 
located under the Patient Lookup area of 
the Physician Base screen (see Figure 8). 
After entering in the patient medical 
record number, click on the Name 
Lookup button. If the entry was entered 
correctly, the patient will activate and 
his or her first and last names, account 
number, room and bed will populate the 
remaining fields in the Patient Lookup 
area of the screen. 
Myth #2: Now that I am trained to 
enter orders in CAPOE on 68, I 
won't have any support 
CAPOE user support on 6B will be 
available from the date of unit activation 
until the end of March, 2002, after which 
CAPOE assistance is but a phone call 
away. Simply dial ext. 8303, and select 
option #9. The on-call CAPOE 
Enter patient medical 
record number here 
trainer/analyst will return your call 
immediately. 
Following 6B, user support will then 
move to 7B for the Electronic Vital 
Signs/Medication Administration, and 
CAPOE activation during the month of 
April, 2002. 
Myth #3: CAPOE prevents 
medication renewals from working 
The medication renewal process falls 
outside of the CAPOE system. The 
renewal of a medication precipitates 
from the yellow sheet sent by Pharmacy 
and placed on the patient's chart. A 
renew notification also displays on-line 
in the CAPOE Order Profile screen. 
These notifications are an enhancement 
to the current process that is already in 
place. 




NEWS FROM THE LmRARY 
OVID Instruction. 
Contact Barb Iobst at 61 0-402-8408 to arrange for instruction 
in the use of OVID's MEDLINE and its other databases. 
Access to the L VH-Muhlenberg Library 
For the past several months card access was the only way to 
enter the library. The door is now unlocked when the library 
is staffed. Suzanne Rice is generally available in the library 
from 8:00 am-4:30PM Monday-Friday. Her hours may 
fluctuate due to assignments in another part of the building, or 
due to PTO. Her phone number is 484-884-2237. Her pager 
number is #1265. 
As in the past you can contact the library at the Cedar Crest 
site directly if you need a MEDLINE search done or a copy of 
an article that is not available in the L VH-Muhlenberg library. 
The main phone number at the Cedar Crest library is 610-
402-8410. The fax number is 410-402-8409. 
Recently Acquired Publications. 
Library at 17tt. and Chew Streets 
Ebersole. Geriatric Nursing and healthy Aging. 2001 
Lee. Medical Care of the Pregnant Patient. 2000 
Library at CC & 1-78 Campus 
Gunter. Dallas Rhinoplasty 2 vol. set. 2002 
DeVita. Cancer. 2002 
Library at LVH-Muhlenberg 
Simon. Emergency Procedures and Techniques. 2001 
Garratt. Mechanisms and Management of Cardiac 
Arrhythmias. 2001 
1 
Computer-Based Training (CBT): 
Computer Based Training (CBT} programs are available for 
L VHHN staff. Topics covered by the CBT programs include: 
Access 2.0 Power-Point 4.0 
Windows NT 4 Word 97 
Excel 97 Access 97 
PowerPoint 97 Lotus 1-2-3 Millennium 
WordPerfect 8 E-mail GUI 
PHAMIS LastWord Inquiry Only commands 
CBT programs replace the instructor-led classes previously 
held at Lehigh Valley Hospital. A proctor will be in the room 
with the learner while he/she takes the CBT, but the learner 
will control the pace and objectives of the learning. 
Computer Based Training takes place in Suite 401 of the 
John & Dorothy Morgan Cancer Center {the computer 
training room) and in the Muhlenberg Hospital Center 
computer training room (off the front lobby). The schedule 
of upcoming dates is as follows: 
CBT sessions for JDMCC, suite 401 are as follows: 
April 23, Sam - noon 
Sessions at MHC, I.S. Training room are as follows: 
May 14, noon- 4pm 
Twelve slots are available for each session. 
To register, please contact Suzanne Rice via e-mail or at 610-
402-2475 with the following: 
date of session 
second date choice 
department 
phone number 
You will receive an e-mail confirming your choice within two 
business days. If you have any questions, please contact Craig 
Koller at 610-402-2413 or through e-mail. 
Any questions, concerns or comments on articles from CEDS, please contact 



















7 am Family Practice GR-
JDMCC IA/B 
7 am Surgical GR CC Aud 
8 am Pediatric GR CC Aud 
12 noon Medical GR CC Aud 
9 
7 am Surgical GR CC Aud 
8 am Pediatric GR CC Aud 
12 noon Medical GR CC Aud 
16 
7 am Surgical GR CC Aud 
8 am Pediatric GR CC Aud 
12 noon Medical GR CC Aud 
23 
7 am Surgical GR CC Aud 
8 am Pediatric GR CC Aud 
I2 noon Medical GR CC Aud 
30 
7 am Surgical GR CC Aud 
8 am Pediatric GR CC Aud 
I2 noon Medical GR CC Aud 
Wed 
3 
I2 noon MHC TB 
ORConfRm 
10 
I2 noon Pulmonary 
TB JDMCC CRt 
17 
I2 noon MHC TB 
ORConfRm 
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8 am Emergency 
MedicineGR 
12 noon Combined 
TBJDMCCCRI 
11 
8 am Emergency 
Medicine GR 
12 noon Combined 
TBJDMCCCRI 
18 
8 am Emergency 
MedicineGR 
I2 noon Combined 
TBJDMCCCRI 
25 
8 am Emergency 
MedicineGR 




7am GYN GR CC CRI 
II am Neurology Conf 
I2 Noon Breast TB JDMCC 
CRI 
12 
7 am OBGYN GR CC CRI 
II am Neurology Conf 
12 Noon Breast TB JDMCC 
CRI 
19 
7 am OBGYN GR CC CRI 
1I am Neurology Conf 
I2 Noon Breast TB JDMCC 
CRI 
26 
7 am OBGYN GR CC CRt 
11 am Neurology Conf 















THERAPEUTICS AT A GLANCE 
The following actions were taken at the February 2002 Therapeutics Committee Meeting- Joseph Ottinger, R.Ph., MS, MBA, Janine 
Barnaby, R.Ph., Jenny Boucher, Phann.D., Jason, Laskosky, Phann.D., Viraj Patel, Pharm.D, 
Adverse Drug Reaction 
The use of low molecular weight heparins (LMWH) continues to increase. Generally, they have been shown to be 
as effective as unfractionated heparin (UFH) in preventing and treating a variety of thrombotic disorders. 
However, as with all anticoagulants they may also elicit unwanted bleeding effects, most of which are minor. The 
safety profile for these drugs has been well studied in controlled patient populations and based on these data, 
prescribed dosing schemes have been identified for treatment and prophylactic uses of these agents. Appropriate 
levels of anticoagulation are assumed, if these dose schedules are utilized. This eliminates the need to routinely 
monitor the usual laboratory coagulation parameters., which are essentially useless in assessing the anticoagulation 
status of patient's receiving low molecular weight heparins. Use of 'alternative' dosing strategies or use in 
populations that were not studied may place the patient at risk for bleeding and/or thrombotic events. Previous 
ADR (Adverse Drug Reaction) reports described here have identified patients that have had bleeding episodes, who 
were renally compromised (estimated creatinine clearance< 30 ml/min.). 
In this quarter's data, we reviewed the cases oftwo patients who developed a spontaneous spinal hematoma, while 
being anticoagulated. The common elements of both cases were use of a low molecular weight heparin, both were 
female and greater than 60 years old. Initially, both patients complained of back pain which was treated with 
injectable ketorolac. Each received two doses of this non-steroidal anti-inflammatory drug before complaining 
about lost sensation and an inability to move their lower limbs. The patients subsequently required decompression 
laminectomies. Neither patient had any clinically significant renal function issues. A summary of these cases are 
outlined below. ...;;.___ 
Patient A, was admitted to the hospital for suspected TIA and atypical chest pain (73yo ). She had received 3 daily 
doses ofwarfarinlOmg during her initial period of hospitalization (INR=l.2) at which point the LMWH was 
discontinued (4 doses administered over 2 days). The anti-platelet agents clopidogrel and aspirin were then started 
and the warfarin discontinued around day 3. The patient's event occurred 24 hours after this latter medication 
change. 
Patient B, ( 60yo) had received a LMWH as an outpatient and was admitted to the hospital for elective surgery and 
was started on unfractionated heparin (highest aPTI achieved =91 sec). This patient's event occurred@ 28 hours 
post admission. 
With the exception of the use ofLMWH around epidural anesthesia and analgesia, these agents have not been 
largely associated with spinal hematomas. Horlacher, et al had previously identified the use of antiplatelet agents 
and LMWH as possibly adding to the risk of epidural hematomas in patients receiving epidural analgesia. It would 
appear from these reports that the use ofketorolac and LMWH should be undertaken with caution in elderly 
females. 
ADR Reporting 
The 4th quarter of2001 saw an increase in the number of ADR's reported. 82 reports were generated 
with the top categories being antibiotics, anticoagulants and narcotic analgesics. There were 12 severe reports that 
are summarized below: 
Patient 1 is a 60 yo who was admitted to the ED for a large drop in his hemoglobin. PTA he was taking rofecoxib 
and upon exam was found to have inflammation of his gastric mucosa and ulcer debris. He was supported with IV 
fluids, blood transfusions and IV pantoprazole. His hemoglobin returned to normal and he was discharged. 
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Patient 2 is a 78 yo discharged on IV penicillin but developed a fever and urticarial rash on arms and trunk. 
Patient's therapy was changed to vancomycin and the patient's symptoms improved. 
Patient 3 is a 45 yo admitted for angioplasty and eptifibatide and heparin were given according to protocol. Later 
the patient became diaphoretic and nauseated with EKG changes. Eptifibatide and heparin were stopped and 
patient was taken to the OR and @180m! of pericardia! fluid was extracted. 
Patient 4 is a 44 yo who presented from another institution with an embolic CV A. Intra-arterial TP A, heparin and 
warfarin were initiated and shortly thereafter a left-sided hemiplegia was found. The medications were stopped due 
to the bleed, but the warfarin and heparin were initiated a few days later and the patient improved. 
Patient 5 is a 69 yo who presented from another institution with a diffuse petechial rash which developed into skin 
sloughing and oral lesions after taking Bactrim. He was transferred to L VH for bum management. He was 
aggressively hydrated, given antibiotics and wound care for TENS. A Med Watch was completed. 
Patient 6 is a 76 yo transferred from another institution with chest pain and increased troponin and at LVH 
underwent an angioplasty where eptifibatide was initiated. Post procedure she developed hematemesis and 
eptifibatide was stopped. An upper GI bleed was found and patient was started on high dose IV pantoprazole. 
Patient 7 is a 64 yo admitted with mental changes secondary to leukemia. She was started on asparaginase for 
leukemia and after receiving a few doses had an anaphylactic reaction. She was given IV diphenhydramine and 
hydrocortisone and returned to baseline within 1 hour. 
Patient 8 is a 74 yo admitted from another institution who underwent emergency catheterization. He had received 
a dose of tenectoplase previously and at L VH received standard doses of abciximab, heparin, aspirin and 
clopidogrel. Over a 9-hour period, the patient developed hypotension and a drop in hemoglobin of 3 gm/dl. His 
medication were held and was given 2 units of blood. Patient made a full recovery. 
Patient 9 is a 74 yo discharged from LVH on levofloxacin. He presented to the ED with a 3-day history of 
weakness. Lab fmdings revealed elevated hepatic enzymes. Levofloxacin was discontinued and Zithromax was 
begun. His labs returned to baseline and the patient was transferred to TSU. 
Patient 10 is a 76 yo admitted to the ED with altered mental status changes due to Pergolide. The medication was 
begun 2 days prior to admission and there had been a decrease in muscle movement and a decrease in intellectual 
response. The pergolide was stopped and over the hospital course her mental status returned to baseline. 
Patients 11 and 12 are discussed following this section. 
Pantoprazole Autosub Amended 
Based on the new renal dose adjustments now recommended for famotidine, patients receiving IV pantoprazole for 
non-GI bleed or non-GERD indications and having an estimated creatinine clearance of< 50 mVmin will be 
changed to famotidine 20mg IV daily. This will eliminate the need to call physicians to implement this 'automatic' 
substitution. Patients with an estimated creatinine clearance of 50 ml/min or more will continue to receive 20mg of 
famotidine every 12 hours. 
Automatic Substitution for Meperidine (Demerol) 
The Therapeutics Committee approved the policy to automatically substitute meperidine with morphine. The 
exceptions are any treatment or prevention of rigors induced by blood products or drugs ( eg. Amphotericin B, 
platelets), postanesthesia shivering, and documented allergy to morphine. The primary problem is the accumulation 
of the toxic metabolite, normeperidine, particularly in the elderly and in patients with renal function impairment. 
This can cause anxiety, tremors, myoclonus, agitation, and seizures. Actually, accumulation has also been observed 
Page25 
in young, otherwise healthy patients given sufficiently high doses. In addition, meperidine has a ceiling effect. 
Higher doses and more frequent administration have little impact on pain relief and may be associated with 
increasing side effects. As a result of these problems, meperidine wiJJ be removed from the narcotic floor stock in 
all areas except the OR. The substitution is listed below. 
Discontinue: Meperidine mg IV liM every hours 
(and Hydroxyzine or Promethazine, if ordered as part of pain therapy) 
Substitute: Morphine Sulfate -----'mg IV liM every ____ hours 
Meperidine 25mg 50mg 75mg 100 mg 
(Demerol) 
Morphine 4mg 6mg 8mg lOmg 
Revision of the Ceftriaxone to Cefotaxime Automatic Substitution 
In light of current recommendations, the policy for dose reductions in ceftriaxone to cefotaxime automatic 
substitutions will be amended to the following: 
Per Therapeutics Committee policy, discontinue Ceftriaxone (Rocephin) 1 g IV Q24h and begin: 
Cefotaxime (Claforan) 1 g IV q8h 
For patients with CrC1~30 mllmin, 
Cefotaxime (Claforan) 1 g IV q 12h 
For patients with CrCl.5 10 mllmin 
Cefotaxime (Claforan) 1 g IV q24h 
No Dosage Ranges for Pain Medications 
After our JCAHO survey in December 2000, we were notified, that dosage ranges CANNOT be written for pain 
medications. (eg. Morphine 2-4mg IV or Tylenol #3 1-2 tabs). These orders are left to interpretation by the nurse 
and cannot be acted upon. 
Medication orders that have a dosage range and corresponding parameters (eg. BP, HR, etc) are acceptable. 
If an order is written for a pain medication with a dosage range, either nursing or pharmacy will contact you to 
clarify the order. 
All preprinted order forms are or have been changed, to comply with JCAHO regulations. 
"That's what it says: 'one tablespoonful, 
300 times a day."' 




Information and Advice About Our Laboratory 
Health Network Laboratories (HNL), along with L VHHN, began using 
plastic collection tubes for blood specimens approximately two years ago. 
Since that time, a dramatic increase in the use of lavender (purple) 
pediatric size tubes has occurred. 
A safety concern arises when lavender capped pediatric tubes are utilized: 
Contents must be manually decanted into larger sized tubes prior to testing. 
Removing caps not only presents a safety issue, but may also affect testing 
turn around time. 
Standard size plastic lavender top tubes yield a 3ml sample when 
completely filled. This volume is exactly the same as that of a pediatric 
size tube. 
At HNL we are continually striving to maintain the highest safety standards 
while providing you with the best possible service. If you have any 
phlebotomy or safety questions, please call Customer Care at 610-402-8170. 
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INDEPENDENT 
URGENT- FOR PHYSICIAN'S PERSONAL ATTENTION 
Subject: Suicide Prevention- Fully Informed Consent With Accutane 
Dear Doctor: 
On December 5, 2000, the Committee on Government Reform, which I chair, conducted 
a hearing regarding the potential link between the acne drug Accutane and depression and 
suicide. Accutane (isotretinoin) is a drug approved by the FDA to treat the most serious form of 
acne -- a type that is painful, permanently disfiguring, and does not respond to other acne 
treatments. However, the FDA has recognized that this medication has a serious and potentially 
dangerous side effect. In some instances, Accutane users become severely depressed and 
vulnerable to thoughts of suicide. 
To date, the Food and Drug Administration (FDA), through its MedWatch reporting 
system, has received reports of 140 suicides, 176 suicide attempts, and 1,156 serious depression-
related events related to Accutane. Many of these reports were for adversely affected teenagers. 
Given that MedWatch is a voluntary reporting system and that FDA officials in the past have 
suggested that only between one and ten percent of adverse events are reported, the actual 
numbers may be much higher. 
In February 1998, the FDA issued warnings to physicians and advised the manufacturer, 
Roche Pharmaceuticals to include the following warning in the labeling: 
"Psychiatric Disorders: Accutane may cause depression, psychosis and, rarely, 
suicidal ideation, suicide attempts and suicide. Discontinuation of Accutane 
therapy may be insufficient; further evaluations may be necessary ... of patients 
reporting depression, some reported that the depression subsided with 
discontinuation of therapy and recurred with reinstitution of therapy. " 
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At our Committee hearing, we heard testimony from a number of families whose children 
had either committed suicide or made an attempt while using Accutane. In their testimony, these 
families raised two serious concerns. The purpose of this letter is to share these concerns with 
you in hopes that it will help you better address these issues with your patients. 
1. While Accutane is meant as a treatment of last resort, it is sometimes prescribed before 
trying alternatives with less serious side effects: 
The FDA approved Accutane for use for severe nodular cystic acne. The FDA-approved 
labeling specifically highlights that this product is not to be considered as a product of first 
choice: 
"Because of significant adverse effects associated with its use, Accutane should 
be reserved for patients with severe nodular acne who are unresponsive to 
conventional therapy, including systemic antibiotics. " 
However, we learned from witnesses that Accutane is sometimes being used for less 
severe forms of acne and before other treatments have been tried. 
Michael Bauman, who lost his son Dan to suicide while on Accutane, testified about 
running into a friend who was picking up a prescription for Accutane: 
"When I asked her if she was aware of the potential side effects, she looked at me 
like I was nuts. When I asked if she was counseled by her son 's dermatologist; 
she said she was not. I asked if this drug was prescribed when other drugs had 
failed and found out that it had been prescribed first before any other remedies 
had been tried. I then asked to look at the labeling and letter that came with her 
prescription and found that it made no mention of depression or suicide and the 
pharmacist said nothing about these potential dangers. " 
Mr. Charles Stone, whose son Clay died in January 2000, stated: 
"In October 1999, at the age of 16, his treating physician decided to put Clay on 
Accutane for his mild acne. " 
2. Patients and their parents are not always advised by their physicians of the serious side 
effects associated with Accutane: 
Tragically, we learned that families had not been fully informed about the suicide risks 
associated with Accutane. The FDA's warning to physicians was sent in February 1998. As we 
learned during our hearing, patients who ~ere prescribed Accutane after this were not 
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always informed of this new warning by their physician. Daniel Bauman began taking Accutane 
in June 1999 and received two brochures to review prior to beginning therapy. Neither brochure 
mentioned depression or suicide. Daniel committed suicide in December 1999. His mother, 
Mrs. Bauman, testified: 
"I got on line and used the two key words: Accutane and suicide and found the 
FDA's MedWatch News dated February 26, 1998: 'important new safety 
information about Accutane. ' In addition, I also discovered that the brochures 
Daniel's dermatologist gave us were copywritten in 1996 and 1997, respectively. 
The brochures had no adverse reactions reporting depression, psychosis, suicidal 
ideations, suicide attempts and suicide. I was finding it very hard to believe that 
Daniel's dermatologist had no idea or updated information to hand out to his 
patients. " 
Mr. Stone also testified that they were not informed about the potential link to suicide: 
"There was never any mention of suicide as a side effect. The information that 
Clay brought home from the dermatologist was a brochure dated 1994 and made 
no mention of suicide. " 
As has been widely reported, the teenage son of Michigan Congressman Bart Stupak 
committed suicide while taking Accutane. In a statement released October 5, 2000, 
Congressman Stupak said: 
"As a parent, I would have wanted to know of the risk of depression, suicide 
ideation and suicide, before allowing my child to take this drug. As a legislator, I 
believe that the public has a right to know of all risks associated with prescription 
drugs." 
Our hearing contributed to the development and implementation of a comprehensive 
program to ensure that Accutane patients, and the parents of minors prescribed Accutane, are 
fully informed of this concern and can make informed decisions regarding Accutane treatment. 
This program includes important precautio;nary information, including an explicit informed 
consent form and a patient-friendly Medication Guide. 
This is why I am contacting you and asking for your assistance. If you are prescribing 
Accutane to your patients, or referring patients to a dermatologist for this acne drug, please 
discuss all the potential risks, monitor the patient's emotional status during and after the use of 
Accutane, and otherwise comply with the elements of the above-referenced program. I am sure 
you agree that if this added effort saves just one life, the time will have been well spent. 
While the focus of our hearing and of this letter concerns the need for fully informed 
consent regarding the potential risk of depression or suicide, the risk of birth defects and fetal 
deaths are also of concern. I would also urge that you closely review the newly published 
"Guide to Best Practices," and that you work closely with your patients to ensure that no unborn 
child is put at risk. 
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If you would like more information, please refer to the Committee's website, 
http://www.house.gov/reform under the header for transcripts. The transcript from the December 
5, 2000, hearing is available under the title, "Accutane - Is this Acne Drug Treatment Linked to 
Depression and Suicide?" The FDA also maintains an information page on Accutane 
(http://www.fda.gov/cder/drug/infopage/accutane/default.htm) that includes the product labeling, 
informed consent form and Medication Guide. 
If you have any questions or would prefer a printed copy of this transcript, please contact 
Professional Staff MemberS. Elizabeth Clay at 202-225-5074 (beth.clay@mail.house.gov). 
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